Lab Corp. (LH) Tops Q2 EPS by 6c; Boosts FY15 EPS Outlook

Go back to Lab Corp. (LH) Tops Q2 EPS by 6c; Boosts FY15 EPS Outlook

Lab Corp. (LH) Names New CEO of Covance

July 28, 2015 7:35 AM EDT

Lab Corp. (NYSE: LH) announced that Deborah Keller will succeed Joseph Herring as Chief Executive Officer of Covance Drug Development (Covance). Mr. Herring will retire on July 31 after more than a decade as CEO.

Ms. Keller joined Covance in 1987 and has held senior leadership roles in global operations, quality assurance, and marketing over her tenure. Most recently she served as Executive Vice President, Covance and Group President, R&D Laboratories, where she led the combined central laboratory... More